Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 8.19 SEK 2.12% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vicore Pharma Holding AB
Pre-Tax Income Peer Comparison

Comparables:
BIOG B
BONEX
VITR
SOBI
BIOA B

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Pre-Tax Income
-kr200.4m
CAGR 3-Years
2%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Pre-Tax Income
kr468.8m
CAGR 3-Years
27%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Pre-Tax Income
kr97.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Pre-Tax Income
-kr3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Pre-Tax Income
kr4.2B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Pre-Tax Income
kr276.5m
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
N/A

See Also

What is Vicore Pharma Holding AB's Pre-Tax Income?
Pre-Tax Income
-200.4m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Pre-Tax Income amounts to -200.4m SEK.

What is Vicore Pharma Holding AB's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-20%

Over the last year, the Pre-Tax Income growth was 24%. The average annual Pre-Tax Income growth rates for Vicore Pharma Holding AB have been 2% over the past three years , -20% over the past five years .

Back to Top